STAP's Women's Health Fair in Binghamton
BINGHAMTON, NY (WIVT/WBGH) – Dozens of women came together at the Broome County Library recently to promote the importance of women's health, and getting tested.
The group Communities of Color hosted the Women's Health Fair to connect women with local health resources.
16 local organizations were scheduled to participate, facilitating discussions about health disparities, self-care and personal empowerment.
The Testing and Prevention Navigator at the Southern Tier Aids Program, Luisa Sanchez says, being busy with work or raising a family can make it easy to forget about caring for your own body.
'So, we try to grasp a wide range of ways that women's health can be impacted. And it doesn't necessarily have to be health related. But, you know, stress is a big factor of women's health that sometimes we don't talk about enough. So, we try to find a range of agencies that can help with women's stress as well. To kind of navigate those health outcomes,' says Sanchez.
The event featured free STI testing, and Sanchez says STAP offers free HIV testing all year round.
She hopes to make the health fair an annual event and is looking to host the next one sometime in the Fall.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Vaccine against gonorrhoea to roll out in Scotland
A new vaccine against gonorrhoea will be rolled out in Scotland in August following a UK-wide rise in cases. The illness, which is the second most common sexually transmitted infection (STI) in Scotland is potentially painful and in rare cases can be life-threatening. Scottish cases have risen in recent years, with 5,999 infections in 2023 - a rise of 59% from before the Covid pandemic. Those eligible for the vaccine will include gay and bisexual men at highest risk of infection, as well those involved in selling or exchanging sex, regardless of their gender. Syphilis and drug-resistant gonorrhoea increasing World-first gonorrhoea vaccine launched by NHS England as infections soar Doctors and charities call for gonorrhoea vaccine roll-out Those most affected by gonorrhoea in the UK are those aged 16 to 25, gay and bisexual men, and those of black and Caribbean ancestry. The vaccine, which is 30-40% effective, is also being delivered in England and Northern Ireland. Doctors and charities called for vaccinations earlier this year after the UK's Joint Committee on Vaccination and Immunisation (JCVI) recommended a targeted roll-out in November 2023. The Scottish government is funding the vaccination programme north of the border. Public Health Minister Jenny Minto said the campaign was "urgent and timely since the number of diagnoses has been high and the disease is becoming increasingly difficult to treat with antibiotics". She added: "The science tells us that this vaccine will potentially protect thousands of people and prevent the spread of infection. "Anything which stops people from contracting gonorrhoea in the first place can have huge benefits, including ensuring our health system remains resilient by reducing the amount of treatment needed." Dr Sam Ghebrehewet, head of the vaccination and immunisation division at Public Health Scotland, said the jab was a "welcome new intervention". He said: "This vaccination programme is expected to help control and prevent the spread of gonorrhoea. "Public Health Scotland is working with the Scottish government and colleagues across NHS boards to finalise plans for the rollout of this targeted vaccination, offering to those at increased risk of gonorrhoea from August 2025." The vaccine was not designed for gonorrhoea - it is the meningitis B vaccine currently given to babies. The bacteria that cause the two diseases are so closely related that the MenB jab appears to cut gonorrhoea cases by around a third. However, it will not eliminate the risk of catching gonorrhoea - it is normally caught while having sex without a condom. Prof Andrew Pollard, the chair of the JCVI which recommended the vaccine, said despite it only being 30% effective, it was "worth having" and could have "a huge impact" overall. Gonorrhoea is also becoming increasingly difficult to treat. Most cases are treated with a single dose of antibiotics, but there is an 80-year history of the bacterium which causes gonorrhoea repeatedly evolving resistance to antibiotics. This is also happening to current treatments and is why some doctors are concerned gonorrhoea could one day become untreatable. They say the best way to deal with a drug-resistant infection is to never catch it in the first place.
Medscape
an hour ago
- Medscape
Flu Shot Sparks False HIV Alarm in Dialysis Patient
False-positive HIV test results following influenza vaccination are rare. However, unexpected cross-reactivity remains a concern in the evolution of vaccine formulations. After obtaining her annual flu shot, an 82-year-old woman on haemodialysis (HD) was repeatedly discovered to have positive HIV enzyme-linked immunosorbent assay (ELISA) test results without having risk factors, and previously, the test was negative. Only a more detailed medical history revealed a possible unexpected explanation. A case report by Rayyan Mkahal,MD, a nephrology fellow at the University of Toronto, Toronto, Ontario, Canada, and his colleagues highlights the potential often-overlooked complications associated with the flu vaccine. The Patient and Her History The patient presented for HD with end-stage kidney disease on intermittent HD in one of the dialysis centres. Her medical history was otherwise significant for diabetes mellitus and dyslipidaemia. At the start of HD, the HIV ELISA test result was negative. However, 7 months later, during routine testing, she was unexpectedly found to have a positive HIV ELISA. The patient had never received a blood transfusion and was not sexually active. The patient was clinically stable without evidence of active infection, weight loss, night sweats, fever, chills, or other systemic symptoms. She has no reported recent travel. Findings and Diagnosis On admission, her vital signs, including blood pressure, heart and respiratory rates, oxygen saturation on room air, and temperature, were all within normal limits. Complete blood cell count was within the normal range. Otherwise, her immunisation history included a hepatitis B vaccine before initiating dialysis and yearly flu vaccination, the most recent of which was administered approximately 45 days before detection. Her previous COVID booster vaccine was administered 4 months ago. No illnesses, hospitalisations, or major interim events have occurred since dialysis initiation. Other probable causes of false-positive ELISA results, such as autoimmune diseases, malignancy, or recent infections, were considered but were not supported by clinical history or laboratory evaluation. An HIV polymerase chain reaction was performed 14 weeks after the initial positive test and revealed no viral replication. No HIV testing was performed between weeks 3 and 14; therefore, the precise timing of seroconversion remains unknown. Discussion 'Despite the use of relatively new vaccine formulations, cross-reactivity with ELISA remains a relevant phenomenon. Given that influenza vaccines are given annually, clinicians must remain vigilant to avoid misdiagnosis and treatment. This case highlights the need for increased awareness of this phenomenon and suggests future research to explore the persistence of vaccine-antibody interference in the vulnerable population,' the study authors wrote.
Yahoo
7 hours ago
- Yahoo
CVS responds to Gov. Sanders' New York Times Op-Ed about PBMs
FAYETTEVILLE, Ark. (KNWA/KFTA) — CVS Health is ramping up its campaign against a new Arkansas law that targets pharmacy benefit managers, publicly clashing with Gov. Sarah Huckabee Sanders just hours after she defended the legislation in a guest essay for The New York Times. Act 624, signed by Sanders in April, bars companies from running both a pharmacy and a pharmacy benefit manager (PBM), a model used by CVS. PBMs manage prescription drug benefits for insurers, negotiate prices with drug manufacturers and reimburse pharmacies. In her guest essay on June 10, Sanders wrote that PBMs 'forcibly steer patients away from independent operators' and inflate drug prices. She also wrote that Act 624 lets PBMs keep operating in Arkansas, but, she said, 'they just can't continue to mistreat patients and box out other pharmacies.' Sanders claimed the three largest pharmacy benefit managers handle 80% of U.S. prescriptions and earn 70% of specialty drug revenue through their affiliated pharmacies. 'Now, CVS is threatening to close down every pharmacy it operates in our state — preferring to take its ball and go home rather than divest from its pharmacy benefit management business and actually serve the patients it claims to care about,' Sanders wrote. CVS sues Arkansas over new pharmacy law CVS issued a statement later that day disputing Sanders' characterization of the law, claiming that the new law is about 'choosing winners and losers and rewarding special interests.' 'Out-of-state competitors are disadvantaged,' a CVS spokesperson said. 'In-state competitors, including Walmart, would handsomely benefit from the closures of pharmacies owned by us and others. The losers are the people of Arkansas who will pay more.' CVS says the law could force it to close 23 pharmacies in Arkansas, affecting 340,000 patients, and block its specialty pharmacy from treating 10,000 high-risk patients with cancer, HIV and rare diseases. The company is also challenging Act 624 in federal court, arguing it violates the U.S. Constitution. 'PBMs are the last line of defense between drugmakers that want to charge a lot of money, and the American businesses, unions, health plans, and government agencies that want to provide good benefits to people,' CVS said in its response on June 10. CVS argues the law is unconstitutional because it unfairly targets out-of-state businesses, treats similar companies differently, and conflicts with federal laws like ERISA and Medicare rules. The company also raised concerns about potential conflicts of interest. 'One state representative who co-sponsored this law owns 13 pharmacies by himself,' the company said, linking to state Rep. Brandon Achor's campaign website. Act 624, introduced as House Bill 1150, was backed by the Arkansas Pharmacists Association and Attorney General Tim Griffin, and passed easily. Act 624 is scheduled to take effect January 1, 2026. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
